Joulukuu 2022
Seuraa kanssamme ASH 2022 -kokousta | American Society of Hematology Meeting & Exposition
Uusinta tutkimustietoa ASH 2021 -kokouksesta
Promising Preliminary Efficacy in Patients with Relapsed/Refractory Multiple Myeloma
- / Paul G. Richardson





ASH 2021 abstraktit
The ASH Annual Meeting provides several resources on COVID-19 in hematology
/ BestPractice Nordic
Long-term remission found with combination therapy for young patients with CLL
/ BestPractice Nordic
Polatuzumab vedotin with R-CHP for patients with diffuse large B-Cell lymphoma
/ BestPractice Nordic
ASH 2021 MEDtalks
Relapse vaccine is a promising treatment for patients with AML
/ Bjørn Tore Gjertsen
Real-world outcomes of axi-cel treatment of large B-cell lymphoma
/ Frederick L. Locke
Tilaa BestPractice Nordic -lehti maksutta postilaatikkoosi
Rekisteröidy tai päivitä profiilisi täällä
Onkologia / Hematologia • Nr. 7 • 2021
- Suolistosyöpäseulonta
- Syöpäsolujen leviämismekanismit
- ROR1-reseptori
Lisää ASH 2020
ASH2020: The First-in-Class Anti-CD47 Antibody for AML
/ David A. Sallman
ASH2020: Recurrent Crebbp Mutations in Follicular Lymphoma
/ Joe Schroers-Martin
ASH2020: Promising results for treatment of AML
/ Tapan M. Kadia